The world might see better days soon.
A recent clinical trial in China for the coronavirus vaccine has shown that it manages to trigger an immune response and that it’s safe for humans.
The vaccine is called BBIBP-CorV, which is developed by the Bejing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG).
While it does show promise, wide-spread use can only be confirmed once phase three of the trials conclude. Currently, phase three trials are being done…